Pfizer
Search results
1 day ago · Analyst Chris Schott from J.P. Morgan maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) and keeping the price target at $1,100.00.. Chris Schott has given his Buy rating due to a ...
1 day ago · Over the last 3 months, 20 Wall Street analysts set an average 12-month price target of $1,042.88 for Eli Lilly, with a high of $1,150.00 and a low of $856.00, reflecting a 13.17% increase from ...
5 days ago · Additionally, for those who prefer to give financially, our Lilly Foundation matches donations that provide support to organizations, including those focused on health equity and education. In 2023 alone, the Lilly Foundation matched over $6.2 million in contributions. Because we care about people. Lilly offers a wide variety of volunteer ...
6 days ago · Per Lilly, Kisunla is the only amyloid-targeting therapy that can be discontinued when amyloid plaques clear up, as shown by a PET scan. This will lower treatment costs and burden for patients. In the TRAILBLAZER-ALZ 2 phase III study, around 47% of participants completed treatment at 12 months and 17% completed treatment at six months.
4 days ago · With strong cash flows derived from a stable and diversified product portfolio, Eli Lilly remains on solid financial footing. We expect the company's debt/EBITDA level to fall from close to 1.9 ...
3 days ago · Eli Lilly (LLY-3.47%) and Novo Nordisk (NVO-2.85%) are archrivals thanks to their dueling drugs for weight loss, Zepbound and Wegovy, as well as their competing therapies for type 2 diabetes ...
6 days ago · Eli Lilly stock is up over 50% in 2024 thanks to weight loss drug demand and improving financials. With supply constraints, Eli Lilly is fighting against copycat makers. What Happened: A recent ...
